Filtern
Erscheinungsjahr
Dokumenttyp
- Zeitschriftenartikel (51)
Sprache
- Englisch (49)
- Deutsch (1)
- Mehrsprachig (1)
Referierte Publikation
- ja (51) (entfernen)
Schlagworte
- Bone (6)
- Bioceramics (5)
- Biomaterial (5)
- Ceramics (5)
- Biocompatibility (4)
- Calcium phosphate ceramics (4)
- Calcium alkali orthophosphates (3)
- Calcium phosphate (3)
- Cell-biomaterial interactions (3)
- Coating (3)
Organisationseinheit der BAM
Schwammartige glaskeramische Biowerkstoffe werden zunehmend als Knochenersatzmaterial verwendet und sind bereits im Tierversuch erprobt. Für den optimalen Einsatz dieser gut resorbierbaren Biowerkstoffe ist eine zuverlässige Charakterisierung erforderlich. Im Vordergrund stehen dabei der Herstellungsprozess, über den die offene Porosität kontrolliert eingestellt wird, sowie der Sintervorgang, der die Struktur des keramischen Gerüstmaterials entscheidend prägt. Hier werden mittels Röntgenrefraktionsanalyse und lichtoptischer Bildauswertung sowohl Porosität als auch die innere Oberflächendichte bestimmt. Während mit beiden Verfahren die Porositäten gut übereinstimmen, weichen die Oberflächendichten signifikant voneinander ab. Dieser Unterschied ist hauptsächlich auf mikrostrukturelle Defekte im keramischen Werkstoffgefüge zurückzuführen, die von der Bildanalyse quantitativ nur unvollständig erfasst werden. Dagegen ist die bildanalytische Auswertung der typischen, großporigen Hohlraumstruktur im Vergleich zur Röntgenrefraktion von Vorteil. Die Untersuchungen zeigen, dass die Kombination beider Verfahren eine geeignete Ergänzung darstellt, um die Strukturparameter verlässlich bestimmen zu können. Dies ist auch die wesentliche Voraussetzung für die Optimierung der Materialeigenschaften.
The use of biodegradable bone substitutes is advantageous for alveolar ridge augmentation, since it avoids second-site surgery for autograft harvesting. This study examines the effect of novel, rapidly resorbable calcium phosphates on the expression of bone-related genes and proteins by human bone-derived cells (HBDC) and compares this behavior to that of tricalciumphosphate (TCP). Test materials were a-TCP, and four materials which were created from ß-Rhenanite and its derivatives: R1-ß-Rhenanite (CaNaPO4); R1/M2 composed of CaNaPO4 and MgNaPO4; R1+SiO2 composed of CaNaPO4 and 9% SiO2 (wt%); and R17-Ca2KNa(PO4)2. HBDC were grown on the substrata for 3, 5, 7, 14 and 21 days, counted and probed for various mRNAs and proteins (Type I collagen, osteocalcin, osteopontin, osteonectin, alkaline phosphatase and bone sialoprotein). All substrata supported continuous cellular growth for 21 days. At day 21, surfaces of R1+SiO2 and R17 had the highest number of HBDC. At 14 and 21 days, cells on R1 and on R1+SiO2 displayed significantly enhanced expression of all osteogenic proteins. Since all novel calcium phosphates supported cellular proliferation together with expression of bone-related proteins at least as much as TCP, these ceramics can be regarded as potential bone substitutes. R1 and R1+SiO2 had the most effect on osteoblastic differentiation, thus suggesting that these materials may possess a higher potency to enhance osteogenesis than TCP.
Calcium phosphate coated titanium and titanium alloy are widely used as dental and orthopaedic implants. This study examines the effect of novel calcium titanium and calcium titanium zirconium phosphates suitable for plasma-spraying onto titanium substrata on the expression of bone-related genes and proteins by human bone-derived cells (HBDC) and compares this behavior to that on native titanium and hydroxyapatite-coated titanium. Test materials were an acid etched and sand-blasted titanium surface (Ti-DPS), a plasma-sprayed hydroxyapatite coating (HA), and five materials which were created from CaTi4(PO4)6 (CTP) and CaZr4(PO4)6 (CZP): sintered CaTi4(PO4)6 (CTP-S1), sintered 46CaO·23TiO2·31P2O5 (CTP-S2), sintered CaTiZr3(PO4)6, (CTZP-S1), sintered 46CaO·23ZrO2·31P2O5 (CTZP-S2) and sintered 55CaO·20TiO2·31P2O5 (CTP-S3). HBDC were grown on the substrata for 3, 7, 14 and 21 d, counted and probed for various mRNAs and proteins (type I collagen, osteocalcin, osteopontin, osteonectin, alkaline phosphatase and bone sialoprotein). All substrates significantly affected cellular growth and the temporal expression of an array of bone-related genes and proteins. At 14 and 21 d, cells on CTP-S3 displayed significantly enhanced expression of all osteogenic mRNAs. Surfaces of CTP-S1 and CTP-S3 had the most effect on osteoblastic differentiation inducing a greater expression of an array of osteogenic markers than recorded for cells grown on Ti-DPS and HA, suggesting that these novel materials may possess a higher potency to enhance osteogenesis.
The use of biodegradable bone substitutes is advantageous for alveolar ridge augmentation because it avoids second-site surgery for autograft harvesting. This study examines the effect of novel, rapidly resorbable calcium phosphates and a calcium phosphate bone cement on the expression of bone-related genes and proteins by human bone-derived cells (HBDCs) and compares this behavior to that of tricalciumphosphate (TCP). Test materials were -TCP, two materials with a crystalline phase Ca2KNa(PO4)2 and with a small amorphous portion containing either magnesium potassium phosphate (material denominated GB14) or silica phosphate (material denominated GB9), and a calcium phosphate bone cement (material denominated Biocement D). HBDCs were grown on the substrata for 3, 7, 14, and 21 days, counted, and probed for various mRNAs and proteins (type I collagen, osteocalcin, osteopontin, osteonectin, alkaline phosphatase, and bone sialoprotein). All substrates supported continuous cellular growth for 21 days. In the presence of GB14 and Biocement D specimens cell proliferation was reduced and cell differentiation increased. At day 21, the greatest number of cells was found on GB9 expressing significantly higher levels of bone-related proteins than cells grown on all other surfaces. Because all novel materials facilitated the expression of the osteoblastic phenotype at least as much as TCP and the polystyrene control, these biomaterials can be regarded as excellent candidate bone substitute materials. GB9 induced the highest proliferation and cellular differentiation after 21 days of incubation, suggesting that this material may possess a higher potency for enhancing osteogenesis than TCP. © 2004 Wiley Periodicals, Inc. J Biomed Mater Res 69A: 145-154, 2004
Rapid resorbable, glassy crystalline materials on the basis of calcium alkali orthophosphates
(1995)
Neben Hydroxylapatit (HAp) findet verstärkt auch Tricalciumphosphat (TCP) Anwendung als Knochenersatzmaterial. In der Literatur finden sich widersprüchliche Angaben zur Löslichkeit von TCP. Bedingt durch unterschiedliche Darstellungsverfahren ergeben sich verschiedenartige Materialbeschaffenheiten, die sich erst nach der Implantation durch ein differenziertes Resorptions-verhalten dokumentieren (partikulärer Abbau, chemischer Lösungsprozeß). Zur Klärung derartiger Zusammenhänge in vitro wurden 2 Methoden zur Bestimmung des Lösungsverhaltens untersucht. Dafür wurden TCP-Proben aus verschiedenen Rohstoffen dargestellt, nach unterschiedlichen Temperaturregimen behandelt und/oder einer Nachbehandlung mit Phosphorsäure unterzogen.
Diese Materialien wurden vor allem mittels Röntgenpulverdiffraktometrie und Rasterelektronenmikroskopie charakterisiert. In anschließenden Löslichkeitsuntersuchungen wurden die optimalen Versuchsparameter (Lösungsmittel, Konzentration, Verhältnis Lösungsmittelmenge zur Lösungsoberfläche usw.) sowie geeignete Meßgrößen (Masseverlust, Ionenkonzentration) ermittelt. Die In-vitro-Löslichkeit erwies sich bei sorgfältiger Auswahl der Versuchsbedingungen als sehr wirkungsvolle Charakterisierungsmöglichkeit, die auf synthesebedingte chemische und morphologische Unterschiede sehr empfindlich reagiert.
Translated Abstract
Resorbable bone substitution on the basis of calcium phosphates
Besides hydroxyapatite (HAp), tricalcium phosphate is increasingly being used as bone substitution material. In literature there are contradictory claims of the TCP solubility. As a result of are contradictory claims of the TCP solubility. As a result of different manufacturing processes there are altered material properties, which are documented by different resorption behaviour especielly after implantation (particle separation, chemical solvatation). To clarify of such in vitro connections two methods for determining the solubility were investigated. Especially for this case, TCP samples prepared from different raw materials were synthesized. These samples were given different heat treatments and/or posttreatments with phosphoric acid.
The materials were characterized above all by using X-ray powder diffraction method and scanning electron microscopy. Following investigations of the solubility lead to optimized testing parameters (solvent, concentration, ratio of solvent's quantity to sample surface, etc.) as well as qualified test parameters (lost of weight, ion concentration). When the test conditions were carefully selected, the in vitro solubillity was proved to be a very effective possibility of materials characterisation which is also very sensitive regarding chemical differences caused by synthesizing or morphological differences.